1: Cools-Lartigue J, Marshall JC, Caissie AL, Saraiva VS, Burnier MN Jr. Secretion of interleukin-6 and prostaglandin E2 during uveal melanoma-monocyte in vitro interactions. Exp Eye Res. 2004 Oct;79(4):451-4. PubMed PMID: 15381029.
2: Filho JP, Vianna RN, Coutinho AB, Arthurs B, Burnier MN Jr. Oncocytoma of the caruncle: a clinicopathologic case report. Int Ophthalmol. 2004 Oct-Dec;25(5-6):321-3. Epub 2006 Mar 7. PubMed PMID: 16532295.
3: Saraiva VS, Marshall JC, Cools-Lartigue J, Burnier MN Jr. Cytotoxic effects of violacein in human uveal melanoma cell lines. Melanoma Res. 2004 Oct;14(5):421-4. PubMed PMID: 15457100.
4: Ozdal PC, Kargi S, Göka S, Callejo SA, Hucumenoglu S, Burnier MN Jr. Capillary hemangioma of the caruncle. Can J Ophthalmol. 2004 Aug;39(5):560-2. PubMed PMID: 15491046.
5: Al-Hinai A, Edelstein C, Burnier MN Jr. Unusual case of melanocytoma. Can J Ophthalmol. 2004 Jun;39(4):461-3. PubMed PMID: 15327113.
6: Blanco PL, Caissie AL, Burnier MN Jr. Experimental models of uveal melanoma. Can J Ophthalmol. 2004 Jun;39(4):441-7. Review. PubMed PMID: 15327111.
7: Marshall JC, Caissie AL, Burnier MN Jr. How in vitro techniques have increased our understanding of uveal melanoma cellular biology. Can J Ophthalmol. 2004 Jun;39(4):428-32. Review. PubMed PMID: 15327109.
8: Saraiva VS, Edelstein C, Burnier MN Jr. New prognostic factors in uveal melanomas: potential molecular targets for therapy. Can J Ophthalmol. 2004 Jun;39(4):422-7. Review. PubMed PMID: 15327108.
9: Callejo SA, Al-Khalifa S, Ozdal PC, Edelstein C, Burnier MN Jr. The risk of other primary cancer in patients with uveal melanoma: a retrospective cohort study of a Canadian population. Can J Ophthalmol. 2004 Jun;39(4):397-402. PubMed PMID: 15327105.
10: McLean IW, Saraiva VS, Burnier MN Jr. Pathological and prognostic features of uveal melanomas. Can J Ophthalmol. 2004 Jun;39(4):343-50. Review. PubMed PMID: 15327098.
11: Burnier MN Jr. Current concepts in ocular melanoma: first of a series of CJO special issues. Can J Ophthalmol. 2004 Jun;39(4):317, 319. English, French. PubMed PMID: 15327096.
12: Burnier MN Jr. The charter on medical professionalism: an important issue that concerns us all. Can J Ophthalmol. 2004 Apr;39(3):199-200, 203-4. English, French. PubMed PMID: 15180136.
13: Callejo SA, Marshall JC, Cools-Lartigue J, Saraiva VS, Burnier MN Jr. Macrophage-derived soluble factor enhances melanoma inhibitory activity expression by uveal melanoma cells in vitro. Melanoma Res. 2004 Apr;14(2):91-5. PubMed PMID: 15057037.
14: Burnier MN Jr. The evaluation of scientific information in medicine. Can J Ophthalmol. 2004 Feb;39(1):5-6, 9-10. English, French. PubMed PMID: 15040609.
15: Burnier MN Jr. Telemedicine and tele-ophthalmology: part II. Can J Ophthalmol. 2003 Dec;38(7):537-8, 541-2. English, French. PubMed PMID: 14740796.
16: Burnier MN Jr. The importance of a team approach to research in ophthalmology. Can J Ophthalmol. 2003 Oct;38(6):451, 453-4. English, French. PubMed PMID: 14620031.
17: Ozdal PC, Callejo SA, Codère F, Burnier MN Jr. Benign ocular adnexal tumours of apocrine, eccrine or hair follicle origin. Can J Ophthalmol. 2003 Aug;38(5):357-63. PubMed PMID: 12956276.
18: Figueiredo A, Caissie AL, Callejo SA, McLean IW, Gold P, Burnier MN Jr. Cyclooxygenase-2 expression in uveal melanoma: novel classification of mixed-cell-type tumours. Can J Ophthalmol. 2003 Aug;38(5):352-6. PubMed PMID: 12956275.
19: Burnier MN Jr. Telemedicine and tele-ophthalmology. Can J Ophthalmol. 2003 Aug;38(5):343, 345. English, French. PubMed PMID: 12956273.
20: Nguyen TN, Edelstein C, Mansour M, Burnier MN Jr. Primary choroidal melanoma masquerading as a hemorrhagic lesion in a patient with ocular trauma. Can J Ophthalmol. 2003 Apr;38(3):228-9. PubMed PMID: 12733692.
21: Burnier MN Jr. The value of clinicopathological correlation in patient care, teaching and research in ophthalmology. Can J Ophthalmol. 2003 Feb;38(1):19-22. PubMed PMID: 12608512.
22: Pereira F, Carey W, Shibata H, Burnier MN Jr, Wang B. Multiple nevoid malignant melanomas in a patient with AIDS: the role of proliferating cell nuclear antigen in the diagnosis. J Am Acad Dermatol. 2002 Aug;47(2 Suppl):S172-4. PubMed PMID: 12140453.
